Status:
TERMINATED
Supplemental Postoperative Oxygen and Wound Infection in Morbidly Obese Patients
Lead Sponsor:
The Cleveland Clinic
Conditions:
Surgical Wound Infection
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The investigators propose to test the hypothesis that the incidence of major complications related to infection or inadequate healing is reduced in morbidly obese patients given 80% inspired oxygen du...
Detailed Description
Wound infection is a common and serious consequence of anesthesia and surgery. Infection is associated with major complications including intra-abdominal abscess, peritonitis without leakage, and seps...
Eligibility Criteria
Inclusion
- Patients with a BMI \> 35 kg/m2 undergoing open or laparoscopic gastric bypass
Exclusion
- Surgeon does not anticipate primary wound closure
- History of fever or infection within 24 hours of surgery
- History of susceptibility to malignant hyperthermia
- Current heart or lung disease
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00315822
Start Date
May 1 2006
End Date
January 1 2009
Last Update
April 6 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Louisville
Louisville, Kentucky, United States, 40202
2
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195